Market
What will be the primary focus area of HHS investigations in 2025?
2
Peter Daszak•EcoHealth•Daszak•Wuhan•China•National Institutes of Health•NIH•Oversight•James Comer•American
Resolution / Starting Odds
Gain-of-Function Research • 25%
Vaccine Development • 25%
Infectious Disease Control • 25%
Other • 25%
HHS official reports or press releases
Story
HHS Debars EcoHealth Alliance and Peter Daszak for Five Years Over Wuhan Gain-of-Function Research, Citing U.S. Taxpayer Funds
Jan 18, 2025, 04:29 AM
The U.S. Department of Health and Human Services (HHS) has cut off all funding and formally debarred EcoHealth Alliance Inc. and its former President, Dr. Peter Daszak, for five years. This decision follows an eight-month investigation by the Select Subcommittee on the Coronavirus Pandemic, which uncovered evidence that EcoHealth and Daszak facilitated gain-of-function research in Wuhan, China without proper oversight and violated multiple requirements of its multimillion-dollar National Institutes of Health (NIH) grant. The debarment was announced after EcoHealth terminated Dr. Daszak's employment effective January 6, 2024. House Oversight Chairman James Comer stated that the decision is a victory for U.S. taxpayers, American national security, and global safety, emphasizing that EcoHealth and Daszak should never again receive U.S. taxpayer funds given the likely origin of COVID-19 from a lab-related incident involving gain-of-function research.
View original story
Similar markets
Vaccine policy reform • 25%
Healthcare system overhaul • 25%
Public health initiatives • 25%
Other • 25%
Healthcare Reform • 25%
Other • 25%
Pharmaceutical Regulation • 25%
Vaccine Policy • 25%
Medicare Advantage reforms • 25%
Other healthcare issues • 25%
Prescription drug pricing • 25%
Medicare for All proposals • 25%
Science and Technology • 25%
Cybersecurity • 25%
Emergency Preparedness • 25%
Telecommunications • 25%
Vaccine Policy • 25%
Chronic Disease • 25%
Health Risks and Climate Change • 25%
Other • 25%
Other • 25%
Water fluoridation • 25%
Healthcare access • 25%
Vaccine policies • 25%
Cartel dismantling • 25%
Domestic terrorism • 25%
Other focus area • 25%
Cybercrime prevention • 25%
Infrastructure Protection • 25%
Cybersecurity • 25%
Immigration • 25%
Counterterrorism • 25%
Criminals • 25%
Drug cartels • 25%
Human traffickers • 25%
Visa overstays • 25%
Other • 25%
Infrastructure • 25%
Healthcare • 25%
Technology • 25%
Enhanced oversight • 25%
Funding restrictions • 25%
Increased transparency • 25%
No major changes • 25%
Workforce reduction • 25%
Regulatory reforms • 25%
Other • 25%
Program cuts • 25%